On this page
equate ibuprofen
Ibuprofen · Suspension
Overview
Active ingredients
Source: NDC Directory| Ingredient | Strength | RxCUI | Monograph |
|---|---|---|---|
| Ibuprofen | 100 mg/5mL | 310965 | View |
Forms, strengths and routes
Source: NDC DirectoryPharmacologic classes are listed in the class section below.
Pharmacologic class
Source: NDC Directory| Class | Type | Browse |
|---|---|---|
| Anti-Inflammatory Agents | EPC | All 251 members |
| Cyclooxygenase Inhibitors [MoA] | MoA | All 251 members |
| Non-Steroidal [CS] | CS | All 251 members |
| Nonsteroidal Anti-inflammatory Drug [EPC] | EPC | All 251 members |
Regulatory status
Source: Drugs@FDANDC Directory| Product | Trade name | Form | Strength | Ingredient | Status | TE | Flags |
|---|---|---|---|---|---|---|---|
| 074937-001 | CHILDREN'S IBUPROFEN | SUSPENSION | IBUPROFEN | Over-the-counter | — |
Approval history
Source: Drugs@FDA| Type | No. | Action | Status | Date | Review |
|---|---|---|---|---|---|
| Supplement | 57 | Labeling | Approved | May 18, 2011 | — |
| Supplement | 40 | Labeling | Approved | March 17, 2006 | — |
| Supplement | 23 | Manufacturing (CMC) | Approved | November 26, 2002 | — |
| Supplement | 22 | Manufacturing (CMC) | Approved | November 26, 2002 | — |
| Supplement | 24 | Labeling | Approved | August 2, 2002 | — |
| Supplement | 20 | Manufacturing (CMC) | Approved | August 21, 2001 | — |
| Supplement | 21 | Labeling | Approved | August 3, 2001 | — |
| Supplement | 19 | Manufacturing (CMC) | Approved | July 30, 2001 | — |
| Supplement | 18 | Manufacturing (CMC) | Approved | July 30, 2001 | — |
| Supplement | 17 | Labeling | Approved | July 30, 2001 | — |
| Supplement | 16 | Manufacturing (CMC) | Approved | July 30, 2001 | — |
| Supplement | 15 | Manufacturing (CMC) | Approved | July 30, 2001 | — |
| Supplement | 14 | Manufacturing (CMC) | Approved | July 30, 2001 | — |
| Supplement | 13 | Manufacturing (CMC) | Approved | July 30, 2001 | — |
| Supplement | 12 | Labeling | Approved | July 30, 2001 | — |
| Supplement | 11 | Manufacturing (CMC) | Approved | July 30, 2001 | — |
| Supplement | 10 | Manufacturing (CMC) | Approved | July 30, 2001 | — |
| Supplement | 9 | Manufacturing (CMC) | Approved | July 30, 2001 | — |
| Supplement | 7 | Labeling | Approved | July 30, 2001 | — |
| Supplement | 6 | Manufacturing (CMC) | Approved | July 30, 2001 | — |
| Supplement | 5 | Manufacturing (CMC) | Approved | July 30, 2001 | — |
| Supplement | 4 | Labeling | Approved | March 27, 2001 | — |
| Supplement | 2 | Manufacturing (CMC) | Approved | January 28, 2000 | — |
| Supplement | 1 | Labeling | Approved | April 26, 1999 | — |
| Original application | 1 | Approved | December 22, 1998 | — |
Prescribing information
Source: openFDA Drug LabelingReproduced verbatim from the Structured Product Labeling submitted to the FDA (effective 20250523). This is the manufacturer's labelling text, not a summary and not advice.
Indications and Usage
openFDA Drug LabelingUses temporarily: • relieves minor aches and pains due to the common cold, flu, sore throat, headache and toothache • reduces fever
Purpose
openFDA Drug LabelingPurposes Pain reliever/fever reducer
Dosage and Administration
openFDA Drug LabelingDirections • this product does not contain directions or complete warnings for adult use • do not give more than directed • shake well before using • mL = milliliter • find right dose on chart. If possible, use weight to dose; otherwise use age. • use only enclosed dosing cup. Do not use any other dosing device. • if needed, repeat dose every 6-8 hours • do not use more than 4 times a day • replace original bottle cap to maintain child resistance • wash dosage cup after each use Dosing Chart Weight (lb) Age (yr) Dose (mL)** under 24 lbs under 2 years ask a doctor 24-35 lbs 2-3 years 5 mL 36-47 lbs 4-5 years 7.5 mL 48-59 lbs 6-8 years 10 mL 60-71 lbs 9-10 years 12.5 mL 72-95 lbs 11 years 15 mL **or as directed by a doctor
Warnings
openFDA Drug LabelingWarnings Allergy alert: Ibuprofen may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include: • hives • facial swelling • asthma (wheezing) • shock • skin reddening • rash • blisters If an allergic reaction occurs, stop use and seek medical help right away. Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if your child: • has had stomach ulcers or bleeding problems • takes a blood thinning (anticoagulant) or steroid drug • takes other drugs containing prescription or nonprescription NSAIDs (aspirin, ibuprofen, naproxen, or others) • takes more or for a longer time than directed Heart attack and stroke warning: NSAIDs, except aspirin, increase the risk of heart attack, heart failure, and stroke. These can be fatal. The risk is higher if you use more than directed or for longer than directed. Sore throat warning: Severe or persistent sore throat or sore throat accompanied by high fever, headache, nausea, and vomiting may be serious. Consult doctor promptly. Do not use more than 2 days or administer to children under 3 years of age unless directed by doctor. Do not use • if the child has ever had an allergic reaction to ibuprofen or any other pain reliever/fever reducer • right before or after heart surgery Ask a doctor before use if • stomach bleeding warning applies to your child • child has a history of stomach problems, such as heartburn • child has problems or serious side effects from taking pain relievers or fever reducers • child has not been drinking fluids • child has lost a lot of fluid due to vomiting or diarrhea • child has high blood pressure, heart disease, liver cirrhosis, kidney disease, or had a stroke • child has asthma • child is taking a diuretic Ask a doctor or pharmacist before use if the child is • under a doctor’s care for any serious condition • taking any other drug When using this product • give with food or milk if stomach upset occurs Stop use and ask a doctor if • child experiences any of the following signs of stomach bleeding: • feels faint • vomits blood • has bloody or black stools • has stomach pain that does not get better • child has symptoms of heart problems or stroke: • chest pain • trouble breathing • weakness in one part or side of body • slurred speech • leg swelling • the child does not get any relief within first day (24 hours) of treatment • fever or pain gets worse or lasts more than 3 days • redness or swelling is present in the painful area • any new symptoms appear Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
Do Not Use
openFDA Drug LabelingDo not use • if the child has ever had an allergic reaction to ibuprofen or any other pain reliever/fever reducer • right before or after heart surgery
Ask a Doctor
openFDA Drug LabelingAsk a doctor before use if • stomach bleeding warning applies to your child • child has a history of stomach problems, such as heartburn • child has problems or serious side effects from taking pain relievers or fever reducers • child has not been drinking fluids • child has lost a lot of fluid due to vomiting or diarrhea • child has high blood pressure, heart disease, liver cirrhosis, kidney disease, or had a stroke • child has asthma • child is taking a diuretic
Stop Use
openFDA Drug LabelingStop use and ask a doctor if • child experiences any of the following signs of stomach bleeding: • feels faint • vomits blood • has bloody or black stools • has stomach pain that does not get better • child has symptoms of heart problems or stroke: • chest pain • trouble breathing • weakness in one part or side of body • slurred speech • leg swelling • the child does not get any relief within first day (24 hours) of treatment • fever or pain gets worse or lasts more than 3 days • redness or swelling is present in the painful area • any new symptoms appear
Active Ingredient
openFDA Drug LabelingActive ingredient (in each 5 mL) Ibuprofen 100 mg (NSAID)* *nonsteroidal anti-inflammatory drug
Adverse event reports
Source: openFDA FAERSAttributed to this product's most-reported active ingredient: IBUPROFEN. Combination products with more than six active ingredients are not attributed, because a report count summed across a long ingredient list measures the list, not the medicine.
Packaging and NDCs
Source: NDC Directory| Package NDC | Product NDC | Labeler | Description | Marketing start |
|---|---|---|---|---|
| 49035-166-26 | 49035-166 | Wal-Mart Stores Inc | 1 BOTTLE in 1 CARTON (49035-166-26) / 118 mL in 1 BOTTLE | April 16, 2002 |
| 49035-166-34 | 49035-166 | Wal-Mart Stores Inc | 1 BOTTLE in 1 CARTON (49035-166-34) / 237 mL in 1 BOTTLE | July 17, 2015 |
| 49035-660-26 | 49035-660 | Wal-Mart Stores Inc | 1 BOTTLE in 1 CARTON (49035-660-26) / 118 mL in 1 BOTTLE | August 19, 2010 |
| 49035-897-26 | 49035-897 | Wal-Mart Stores Inc | 1 BOTTLE in 1 CARTON (49035-897-26) / 118 mL in 1 BOTTLE | February 2, 1999 |
| 49035-897-34 | 49035-897 | Wal-Mart Stores Inc | 1 BOTTLE in 1 CARTON (49035-897-34) / 237 mL in 1 BOTTLE | December 16, 2010 |
| 49035-166 | 49035-166 | Wal-Mart Stores Inc | — | April 16, 2002 |
| 49035-660 | 49035-660 | Wal-Mart Stores Inc | — | August 19, 2010 |
| 49035-897 | 49035-897 | Wal-Mart Stores Inc | — | February 2, 1999 |
Sources for this page
| Dataset | Agency | Used for |
|---|---|---|
| NDC Directory | FDA | Identity, ingredients, strengths, forms, routes, labelers, packages |
| Drugs@FDA | FDA | Application, sponsor, submissions, review documents, marketing status |
| Drug Labeling | FDA / NLM | Prescribing information reproduced above |
| FAERS | FDA | Adverse event report counts |
Generated September 25, 2026 · 11 sections on this page.